0

    538964

    MERCURYLAB

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Mercury Laboratories Limited Share Price Today

    Investment Returns

    Over 1 Month -1.51% Over 3 Months 4.83% Over 6 Months 3.50% Over 1 Year -9.07%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Mercury Laboratories Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 94.80
    • P/E Ratio (TTM) 23.41
    • Beta 0.62
    • Book Value / share 484.00
    • Return on equity 6.01%
    • EPS (TTM) 36.59
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.30
    info icon alternate text

    Mercury Laboratories Limited Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 15.96
    Operating Expense 15.62
    Net Profit 0.30
    Net Profit Margin (%) 1.87
    Earnings Per Share (EPS) 2.48
    EBITDA 1.24
    Effective Tax Rate (%) 23.07
    Particulars MAR 2026 (Values in Cr)
    Revenue 20.44
    Operating Expense 19.38
    Net Profit 1.23
    Net Profit Margin (%) 6.01
    Earnings Per Share (EPS) 10.21
    EBITDA 2.71
    Effective Tax Rate (%) 29.31
    Particulars DEC 2025 (Values in Cr)
    Revenue 18.35
    Operating Expense 16.84
    Net Profit 1.00
    Net Profit Margin (%) 5.44
    Earnings Per Share (EPS) 8.31
    EBITDA 2.44
    Effective Tax Rate (%) 30.06
    Particulars SEP 2025 (Values in Cr)
    Revenue 19.01
    Operating Expense 17.86
    Net Profit 1.64
    Net Profit Margin (%) 8.62
    Earnings Per Share (EPS) 13.69
    EBITDA 2.90
    Effective Tax Rate (%) 14.58
    Particulars JUN 2025 (Values in Cr)
    Revenue 18.14
    Operating Expense 16.77
    Net Profit 0.97
    Net Profit Margin (%) 5.34
    Earnings Per Share (EPS) 8.06
    EBITDA 2.54
    Effective Tax Rate (%) 37.41
    Particulars MAR 2026 (Values in Cr)
    Revenue 75.94
    Operating Expense 70.85
    Net Profit 4.83
    Net Profit Margin (%) 6.36
    Earnings Per Share (EPS) 40.28
    EBITDA 10.60
    Effective Tax Rate (%) 27.10
    Particulars MAR 2025 (Values in Cr)
    Revenue 75.10
    Operating Expense 71.50
    Net Profit 3.14
    Net Profit Margin (%) 4.18
    Earnings Per Share (EPS) 26.21
    EBITDA 8.09
    Effective Tax Rate (%) 32.61
    Particulars MAR 2024 (Values in Cr)
    Revenue 75.56
    Operating Expense 69.72
    Net Profit 5.65
    Net Profit Margin (%) 7.47
    Earnings Per Share (EPS) 47.12
    EBITDA 10.12
    Effective Tax Rate (%) 18.35
    Particulars MAR 2023 (Values in Cr)
    Revenue 75.33
    Operating Expense 69.61
    Net Profit 5.58
    Net Profit Margin (%) 7.40
    Earnings Per Share (EPS) 46.49
    EBITDA 10.28
    Effective Tax Rate (%) 25.13
    Particulars MAR 2022 (Values in Cr)
    Revenue 57.92
    Operating Expense 53.84
    Net Profit 3.56
    Net Profit Margin (%) 6.14
    Earnings Per Share (EPS) 29.68
    EBITDA 7.93
    Effective Tax Rate (%) 29.22
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 446.41
    ROE % 6.01
    ROCE % 8.98
    Total Debt to Total Equity 0.11
    EBITDA Margin 10.77
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 423.65
    ROE % 11.71
    ROCE % 13.50
    Total Debt to Total Equity 0.12
    EBITDA Margin 13.39
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 380.24
    ROE % 12.99
    ROCE % 15.78
    Total Debt to Total Equity 0.14
    EBITDA Margin 13.66
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 335.89
    ROE % 9.22
    ROCE % 11.81
    Total Debt to Total Equity 0.17
    EBITDA Margin 13.71
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 307.45
    ROE % 15.51
    ROCE % 19.97
    Total Debt to Total Equity 0.21
    EBITDA Margin 15.26
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.19
    Total Assets 74.23
    Total Liabilities 74.23
    Total Equity 53.56
    Share Outstanding 0
    Price to Book Ratio 1.83
    Return on Assets (%) 4.23
    Return on Capital (%) 5.45
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.22
    Total Assets 67.95
    Total Liabilities 67.95
    Total Equity 50.83
    Share Outstanding 0
    Price to Book Ratio 1.96
    Return on Assets (%) 8.32
    Return on Capital (%) 10.04
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 7.31
    Total Assets 64.16
    Total Liabilities 64.16
    Total Equity 45.62
    Share Outstanding 0
    Price to Book Ratio 1.54
    Return on Assets (%) 8.69
    Return on Capital (%) 10.94
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 6.93
    Total Assets 62.43
    Total Liabilities 62.43
    Total Equity 40.30
    Share Outstanding 0
    Price to Book Ratio 1.44
    Return on Assets (%) 5.70
    Return on Capital (%) 7.84
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 4.86
    Total Assets 65.37
    Total Liabilities 65.37
    Total Equity 36.89
    Share Outstanding 0
    Price to Book Ratio 2.09
    Return on Assets (%) 8.16
    Return on Capital (%) 12.37
    Particulars MAR 2025 (Values in Cr)
    Net Income 4.66
    Cash from Operations 6.39
    Cash from Investing -9.03
    Cash from Financing -0.99
    Net change in Cash -6.03
    Free Cash Flow 15.43
    Particulars MAR 2024 (Values in Cr)
    Net Income 6.92
    Cash from Operations 9.48
    Cash from Investing -6.27
    Cash from Financing -1.04
    Net change in Cash 0.91
    Free Cash Flow 15.75
    Particulars MAR 2023 (Values in Cr)
    Net Income 7.44
    Cash from Operations 3.55
    Cash from Investing -1.05
    Cash from Financing -1.01
    Net change in Cash 0.38
    Free Cash Flow 4.61
    Particulars MAR 2022 (Values in Cr)
    Net Income 5.03
    Cash from Operations 7.10
    Cash from Investing -1.89
    Cash from Financing -1.23
    Net change in Cash 2.06
    Free Cash Flow 9.01
    Particulars MAR 2021 (Values in Cr)
    Net Income 7.90
    Cash from Operations 9.58
    Cash from Investing -4.61
    Cash from Financing -1.23
    Net change in Cash 2.35
    Free Cash Flow 14.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 17.60 2.05 325.08 23.12 43.00
    BLISS GVS PHARMA LTD 488.95 39.37 4.35 5194.80 118.35 552.90
    CIPLA LTD. 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LTD. 546.75 25.57 3.95 1609.14 256.40 551.25
    GLAXOSMITHKLINE PHARMA LT 2647.45 42.60 19.77 44849.40 2088.00 2935.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 29.66 5.46 325.08 23.12 43.00
    AMRUTANJAN HEALTH CARE LTD. 517.35 23.19 4.03 1495.69 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8173.90 106.82 23.41 20434.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 488.95 52.92 4.49 5194.80 118.35 552.90

    Mercury Laboratories Limited shareholding pattern

    Holding
    26.34%
    73.65%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Mercury Laboratories Limited Technicals Summary

    790.00 -2.76 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 799.30
    • 26 Days 808.10
    • 10 Days 804.80
    • 50 Days 802.30
    • 12 Days 806.40
    • 100 Days 800.00
    • 20 Days 808.80
    • 200 Days 813.80
    804.58 PIVOT
    First Support 785.92 First Resistance 831.17 Second Support 759.33 Second Resistance 849.83 Third Support 740.67 Third Resistance 876.42
    RSI 50.89 ADX 27.88 MACD -1.68 Williams % R -69.36 Commodity Channel Index (CCI) -41.56
    Date 2026-08-04 Week 27.00 Same Day 68.00 Month 101.00
    1 Year 0.62 3 Year 0.47
    Over 1 Month
    -1.51% down
    Over 1 Year
    -9.07% down
    Over 3 Months
    4.83% down
    Over 3 Years
    0.51% down
    Over 6 Months
    3.50% down
    Over 5 Years
    1.77% down

    Mercury Laboratories Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    06 Aug 2025 3.5 Final 06 Aug 2025 Equity shares
    20 Sep 2024 3.5 Final 21 Sep 2024 Equity shares
    20 Sep 2023 3.5 Final 21 Sep 2023 Equity shares
    19 Sep 2022 3.5 Final 21 Sep 2022 Equity shares
    20 Sep 2021 2.0 Final 22 Sep 2021 Equity shares
    22 Feb 2021 1.5 Interim 23 Feb 2021 Equity shares
    21 Sep 2020 2.0 Final 23 Sep 2020 Equity shares
    19 Sep 2019 1.5 Final 23 Sep 2019 Equity shares
    31 Aug 2018 1.5 Final 04 Sep 2018 Equity shares
    15 Sep 2017 1.5 Final 19 Sep 2017 Equity shares
    15 Sep 2016 1.5 Final 19 Sep 2016 Equity shares
    16 Sep 2015 1.5 Final 19 Sep 2015 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Mercury Laboratories Ltd?

    Answer Field

    Mercury Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 790.00 as on Aug 05 2026 03:12 PM.

    What is the Market Cap of Mercury Laboratories Ltd Share?

    Answer Field

    The market cap of Mercury Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 94.80 as on Aug 05 2026 03:12 PM.

    What is the 52 Week High and Low of Mercury Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Mercury Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 976.00 and ₹ 620.55.

    What is 1 year return for Mercury Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -9.07%.

    What is the P/E Ratio of Mercury Laboratories Ltd Share?

    Answer Field

    As on Aug 05 2026 03:12 PM the price-to-earnings (PE) ratio for Mercury Laboratories Ltd share is 23.41.

    What is the PB ratio of Mercury Laboratories Ltd Share?

    Answer Field

    As on Aug 05 2026 03:12 PM, the price-to-book (PB) ratio for Mercury Laboratories Ltd share is 484.00.

    How to Buy Mercury Laboratories Ltd Share?

    Answer Field

    You can trade in Mercury Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Mercury Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Mercury Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Mercury Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |